Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MERIT MEDICAL SYSTEMS INC Director's Dealing 2016

Dec 12, 2016

31049_dirs_2016-12-12_27123eb7-414b-4f51-8729-88c0f772a746.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MERIT MEDICAL SYSTEMS INC (MMSI)
CIK: 0000856982
Period of Report: 2016-12-08

Reporting Person: STANGER KENT W (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-12-08 Common Stock, No Par Value S 4000 $25.9794 Disposed 422346 Direct
2016-12-09 Common Stock, No Par Value S 8000 $26.416 Disposed 414346 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock, No Par Value 42250 Indirect
Common Stock, No Par Value 4271 Direct
Common Stock, No Par Value 29524 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Non-qualified stock options (right to buy) $13.75 2018-08-11 Common Stock (64000) 64000 Direct
Non-qualified stock options (right to buy) $12.06 2021-10-04 Common Stock (2000) 2000 Direct
Non-qualified stock options (right to buy) $19.72 2023-05-02 Common Stock (9375) 9375 Direct
Non-qualified stock options (right to buy) $18.80 2023-05-26 Common Stock (25000) 25000 Direct

Footnotes

F1: Represents plan holdings as of 12/12/2016.

F2: Employee stock purchase plan holdings as of 12/12/2016.

F3: This report shall not be deemed an admission that the reporting person is the beneficial owner of the securities held by K.W.S. Properties LC.

F4: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.90 to $26.025, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

F5: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.25 to $26.75, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

F6: Becomes exercisable in equal annual installments of 20% commencing on 08/11/2012.

F7: Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015.

F8: Becomes exercisable in equal annual installments of 20% commencing on 05/02/2017.

F9: Becomes exercisable in equal annual installments of 20% commencing on 05/26/2017.